119 related articles for article (PubMed ID: 3119546)
1. 2-Arylidene-4-cyclopentene-1,3-diones designed as non-nitro radiosensitizers and hypoxic cytotoxins.
Hori H; Maezawa H; Iitaka Y; Ohsaka T; Shibata T; Mori T; Inayama S
Jpn J Cancer Res; 1987 Oct; 78(10):1128-33. PubMed ID: 3119546
[TBL] [Abstract][Full Text] [Related]
2. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
Zhou L; Nishimoto S
Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
[TBL] [Abstract][Full Text] [Related]
3. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a series of 3,5-disubstituted benzisoxazole-4,7-diones. Potent radiosensitizers in vitro.
Suto MJ; Stier MA; Winters RT; Turner WR; Pinter CD; Elliott WE; Sebolt-Leopold JS
J Med Chem; 1991 Nov; 34(11):3290-4. PubMed ID: 1956048
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins.
Naylor MA; Stephens MA; Cole S; Threadgill MD; Stratford IJ; O'Neill P; Fielden EM; Adams GE
J Med Chem; 1990 Sep; 33(9):2508-13. PubMed ID: 2391690
[TBL] [Abstract][Full Text] [Related]
7. Some complexes of cobalt(III) and iron(III) are radiosensitizers of hypoxic EMT6 cells.
Teicher BA; Jacobs JL; Cathcart KN; Abrams MJ; Vollano JF; Picker DH
Radiat Res; 1987 Jan; 109(1):36-46. PubMed ID: 3809391
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
[TBL] [Abstract][Full Text] [Related]
9. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents.
Jenkins TC; Stratford IJ; Stephens MA
Anticancer Drug Des; 1989 Aug; 4(2):145-60. PubMed ID: 2803463
[TBL] [Abstract][Full Text] [Related]
10. Development and testing of new hypoxic cell radiosensitizers.
Kimler BF; McDonald T; Cheng CC; Podrebarac EG; Mansfield CM
Radiology; 1979 Nov; 133(2):515-7. PubMed ID: 493545
[TBL] [Abstract][Full Text] [Related]
11. Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety.
Uto Y; Nagasawa H; Jin CZ; Nakayama S; Tanaka A; Kiyoi S; Nakashima H; Shimamura M; Inayama S; Fujiwara T; Takeuchi Y; Uehara Y; Kirk KL; Nakata E; Hori H
Bioorg Med Chem; 2008 Jun; 16(11):6042-53. PubMed ID: 18474428
[TBL] [Abstract][Full Text] [Related]
12. Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers.
Naylor MA; Stephens MA; Stratford IJ; Keohane A; O'Neill P; Threadgill MD; Webb P; Fielden EM; Adams GE
Anticancer Drug Des; 1991 Jul; 6(3):151-67. PubMed ID: 1872946
[TBL] [Abstract][Full Text] [Related]
13. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
[TBL] [Abstract][Full Text] [Related]
15. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
Wideł M; Watras J; Suwiński J; Salwińska E
Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: dependence on reduction potential.
Adams GE; Stratford IJ; Wallace RG; Wardman P; Watts ME
J Natl Cancer Inst; 1980 Mar; 64(3):555-60. PubMed ID: 6928241
[TBL] [Abstract][Full Text] [Related]
18. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
Watts ME; Jacobs RS
Br J Cancer Suppl; 1978 Jun; 3():80-3. PubMed ID: 277262
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
Skov KA; Adomat H; Doedee M; Farrell N
Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
[TBL] [Abstract][Full Text] [Related]
20. An approach to the design and synthesis of mercaptoimidazole derivatives containing oxidized sulfur based on electron affinity sensitization.
Inayama S; Hori H; Ohsaka T; Mori T; Shibata C
Gan; 1981 Feb; 72(1):156-9. PubMed ID: 7274641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
